Abstract:Induced pluripotent stem cell (iPSC) technology has the potential to transform regenerative medicine. It also offers a powerful tool for establishing in vitro models of disease, in particular, for neuropsychiatric disorders where live human neurons are essentially impossible to procure. Using iPSCs derived from three schizophrenia (SZ) patients, one of whom has 22q11.2del (velocardiofacial syndrome; VCFS), the authors developed a culture system to study SZ on a molecular and cellular level. SZ iPSCs were differentiated into functional, primarily glutamatergic neurons that were able to fire action potentials after ∼8 weeks in culture. Early differentiating neurons expressed a number of transcription factors/chromatin remodeling proteins and synaptic proteins relevant to SZ pathogenesis, including ZNF804A, RELN, CNTNAP2, CTNNA2, SMARCA2, and NRXN1. Although a small number of lines were developed in this preliminary study, the SZ line containing 22q11.2del showed a significant delay in the reduction of endogenous OCT4 and NANOG expression that normally occurs during differentiation. Constitutive expression of OCT4 has been observed in Dgcr8-deficient mouse embryonic stem cells (mESCs); DGCR8 maps to the 22q11.2-deleted region. These findings demonstrate that the method of inducing neural differentiation employed is useful for disease modeling in SZ and that the transition of iPSCs with 22q11.2 deletions towards a differentiated state may be marked by subtle changes in expression of pluripotency-associated genes.

Characterization of the human induced pluripotent stem cell (iPSC) SZGJMSi004-A line from a 28-year-old Han male patient with depression

Generation and characterization of human-derived iPSC lines from two cousins with schizophrenia and bipolar disorder and their unaffected cousin

Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia.

Establishment of Induced Pluripotent Stem Cell Line (Zzui010-A) from an Alzheimer's Disease Patient Carrying an APP Gene Mutation.

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Generation of Refractory Schizophrenia Patient-Derived Induced Pluripotent Stem Cell Line UJSi001-A.

Generation of Patient-Derived Induced Pluripotent Stem Cell Line UJSi004-A from Ultra-Treatment-resistant Schizophrenia

Construction of Induced Pluripotent Stem Cell Line (Zzui031-A) of a Healthy Young Chinese Han Male

Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Induced Pluripotent Stem Cell Line (Zzuneui011-A) Derived from Peripheral Blood Mononuclear Cells (pbmcs) of a Healthy 27-Year-old Female Individual.

Generation and Characterization of Ipscs from a Patient with Obsessive–compulsive Disorder, His Mother with Schizophrenia and His Healthy Father

Application of Induced Pluripotent Stem Cells to Understand Neurobiological Basis of Bipolar Disorder and Schizophrenia

Generation of Ultra-Treatment-resistant Schizophrenia Patient-Derived Induced Pluripotent Stem Cell Line UJSi002-A

Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor

Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Establishment of an Induced Pluripotent Stem Cell Line (Sdchi011-A) from a Healthy Chinese Female Donor

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli001-A) from PBMCs of a Healthy Male Donor.

Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells from different genders